DiagnoCure gets European distributor for bladder test:
This article was originally published in Clinica
Dutch company BioProCon Medical has gained exclusive distribution rights to DiagnoCure's bladder cancer test ImmunoCyt in Germany, Belgium and the Netherlands. ImmunoCyt uses monoclonal antibodies to detect tumour antigens expressed on superficial bladder tumours. The test is already distributed in the US. BioProCon, which is based in Nijmegen, develops products for genito-urinary diseases.